FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309634793> ?p ?o ?g. }

• W4309634793 endingPage "47" @default.
• W4309634793 startingPage "39" @default.
• W4309634793 abstract "Type 2 diabetes is characterized by progressive decline in pancreatic β-cell function. Newer agents, such as glucagon-like peptide-1 receptor agonist (GLP-1RA) and dual incretin agonists, can augment β-cell function and delay the need for additional antihyperglycemics. However, the effect on β-cell function ceases after stopping the medications. When combined with intensive lifestyle modifications, higher doses of GLP-1RA than those used for diabetes treatment can be used to induce weight loss. More research is needed on whether the weight loss achieved with GLP1-RA can be sustained after stopping medication and in turn can sustain diabetes remission." @default.
• W4309634793 created "2022-11-28" @default.
• W4309634793 creator A5060127002 @default.
• W4309634793 creator A5060782956 @default.
• W4309634793 creator A5061058170 @default.
• W4309634793 date "2023-03-01" @default.
• W4309634793 modified "2023-10-16" @default.
• W4309634793 title "Intervention with Therapeutic Agents, Understanding the Path to Remission to Type 2 Diabetes" @default.
• W4309634793 cites W1558150471 @default.
• W4309634793 cites W1798757189 @default.
• W4309634793 cites W1975588287 @default.
• W4309634793 cites W2028637607 @default.
• W4309634793 cites W2029228033 @default.
• W4309634793 cites W2054564814 @default.
• W4309634793 cites W2069942402 @default.
• W4309634793 cites W2089557095 @default.
• W4309634793 cites W2104938107 @default.
• W4309634793 cites W2140978079 @default.
• W4309634793 cites W2148798434 @default.
• W4309634793 cites W2159859567 @default.
• W4309634793 cites W2163457223 @default.
• W4309634793 cites W2169274492 @default.
• W4309634793 cites W2398771848 @default.
• W4309634793 cites W2919203803 @default.
• W4309634793 cites W2924479779 @default.
• W4309634793 cites W2942388295 @default.
• W4309634793 cites W2963422972 @default.
• W4309634793 cites W2971401138 @default.
• W4309634793 cites W2978840913 @default.
• W4309634793 cites W3013213902 @default.
• W4309634793 cites W3028349792 @default.
• W4309634793 cites W3127371223 @default.
• W4309634793 cites W3129305070 @default.
• W4309634793 cites W3133181364 @default.
• W4309634793 cites W3133746780 @default.
• W4309634793 cites W3138431202 @default.
• W4309634793 cites W3177122952 @default.
• W4309634793 cites W3177393241 @default.
• W4309634793 cites W3191712049 @default.
• W4309634793 cites W3196921676 @default.
• W4309634793 cites W3200923526 @default.
• W4309634793 cites W4210940103 @default.
• W4309634793 cites W4220955649 @default.
• W4309634793 cites W4234995814 @default.
• W4309634793 cites W4241784903 @default.
• W4309634793 cites W807162506 @default.
• W4309634793 doi "https://doi.org/10.1016/j.ecl.2022.07.004" @default.
• W4309634793 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36754496" @default.
• W4309634793 hasPublicationYear "2023" @default.
• W4309634793 type Work @default.
• W4309634793 citedByCount "0" @default.
• W4309634793 crossrefType "journal-article" @default.
• W4309634793 hasAuthorship W4309634793A5060127002 @default.
• W4309634793 hasAuthorship W4309634793A5060782956 @default.
• W4309634793 hasAuthorship W4309634793A5061058170 @default.
• W4309634793 hasBestOaLocation W43096347932 @default.
• W4309634793 hasConcept C104317684 @default.
• W4309634793 hasConcept C105951970 @default.
• W4309634793 hasConcept C126322002 @default.
• W4309634793 hasConcept C127716648 @default.
• W4309634793 hasConcept C134018914 @default.
• W4309634793 hasConcept C170493617 @default.
• W4309634793 hasConcept C185592680 @default.
• W4309634793 hasConcept C2776398474 @default.
• W4309634793 hasConcept C2777180221 @default.
• W4309634793 hasConcept C2778881409 @default.
• W4309634793 hasConcept C2778938600 @default.
• W4309634793 hasConcept C2780533449 @default.
• W4309634793 hasConcept C511355011 @default.
• W4309634793 hasConcept C544821477 @default.
• W4309634793 hasConcept C55493867 @default.
• W4309634793 hasConcept C555293320 @default.
• W4309634793 hasConcept C71924100 @default.
• W4309634793 hasConceptScore W4309634793C104317684 @default.
• W4309634793 hasConceptScore W4309634793C105951970 @default.
• W4309634793 hasConceptScore W4309634793C126322002 @default.
• W4309634793 hasConceptScore W4309634793C127716648 @default.
• W4309634793 hasConceptScore W4309634793C134018914 @default.
• W4309634793 hasConceptScore W4309634793C170493617 @default.
• W4309634793 hasConceptScore W4309634793C185592680 @default.
• W4309634793 hasConceptScore W4309634793C2776398474 @default.
• W4309634793 hasConceptScore W4309634793C2777180221 @default.
• W4309634793 hasConceptScore W4309634793C2778881409 @default.
• W4309634793 hasConceptScore W4309634793C2778938600 @default.
• W4309634793 hasConceptScore W4309634793C2780533449 @default.
• W4309634793 hasConceptScore W4309634793C511355011 @default.
• W4309634793 hasConceptScore W4309634793C544821477 @default.
• W4309634793 hasConceptScore W4309634793C55493867 @default.
• W4309634793 hasConceptScore W4309634793C555293320 @default.
• W4309634793 hasConceptScore W4309634793C71924100 @default.
• W4309634793 hasFunder F4320307770 @default.
• W4309634793 hasFunder F4320332161 @default.
• W4309634793 hasIssue "1" @default.
• W4309634793 hasLocation W43096347931 @default.
• W4309634793 hasLocation W43096347932 @default.
• W4309634793 hasLocation W43096347933 @default.
• W4309634793 hasOpenAccess W4309634793 @default.
• W4309634793 hasPrimaryLocation W43096347931 @default.

• next